Frequently Asked Questions
Factors such as increased cases of scarlet fever and growing demand for advanced diagnostic techniques are acting as the major drivers for the global scarlet fever market.
AstraZeneca (U.K.), Lilly (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Novartis AG (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), GSK plc (U.K.), Hikma Pharmaceuticals PLC (U.K.), Cipla Inc. (India), Melinta Therapeutics LLC (U.S.), KYORIN Pharmaceutical Co., Ltd (Japan), NIKSAN PHARMACEUTICAL (India), Maya Biotech Private Limited (India).
The Scarlet Fever Market report is segmented by Treatment, Route of Administration, End-Users, and Distribution Channel
Asia-Pacific dominates the market due to rising government initiatives for infection control and the adoption of new technologies infection control.
